The quest to slow ageing through drug discovery

@article{Partridge2020TheQT,
  title={The quest to slow ageing through drug discovery},
  author={Linda Partridge and Mat{\'i}as Fuentealba and Brian K. Kennedy},
  journal={Nature Reviews Drug Discovery},
  year={2020},
  pages={1-20}
}
Although death is inevitable, individuals have long sought to alter the course of the ageing process. Indeed, ageing has proved to be modifiable; by intervening in biological systems, such as nutrient sensing, cellular senescence, the systemic environment and the gut microbiome, phenotypes of ageing can be slowed sufficiently to mitigate age-related functional decline. These interventions can also delay the onset of many disabling, chronic diseases, including cancer, cardiovascular disease and… 
Mitochondria and Calcium Homeostasis: Cisd2 as a Big Player in Cardiac Ageing
TLDR
A high level of Cisd2 delays cardiac ageing and ameliorates age-related cardiac dysfunction; this occurs by maintaining correct regulation of energy metabolism and allowing dynamic control of metabolic flexibility.
Does Modulation of an Epigenetic Clock Define a Geroprotector?
TLDR
It is argued that studies that enable understanding of the relationships between epigenetic clocks and disease processes while simultaneously testing the efficacy of a candidate geroprotector are crucial to move the field forward.
Advancements in therapeutic drugs targeting of senescence
TLDR
Different types of drugs promoting healthy aging – such as senolytics, senescence-associated secretory phenotype (SASP) inhibitors, and nutrient signaling regulators – are summarized and an update on their potential therapeutic merits is provided.
Iron supplementation delays aging and extends cellular lifespan through potentiation of mitochondrial function
TLDR
Iron supplementation rescued the short lifespan of AMPK knockout mutant and confirmed the anti-aging role through enhancement of mitochondrial functions, suggesting a potential therapeutic use of iron supplementation to delay aging and prolong healthspan.
Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: the regulation and intervention
TLDR
This review focuses on the present findings and emerging concepts in epigenetic, inflammatory, and metabolic regulations and the consequences of the ageing process.
Iron Supplementation Delays Aging and Extends Cellular Lifespan through Potentiation of Mitochondrial Function
TLDR
Iron supplementation rescued the short lifespan of the AMPK knockout mutant and confirmed its anti-aging role through the enhancement of mitochondrial functions, suggesting a potential therapeutic use of iron supplementation to delay aging and prolong healthspan.
Targeting aging mechanisms: pharmacological perspectives
Memorable Food: Fighting Age-Related Neurodegeneration by Precision Nutrition
TLDR
Large-scale cohorts that would include the precise monitoring of food intake, mapping of genetic variants, epigenetic data, microbiome studies, and metabolome, lipidome, and transcriptome data are needed are needed for a personalized diet plan for individual NDD patients.
Redox Dysregulation in Aging and COPD: Role of NOX Enzymes and Implications for Antioxidant Strategies
TLDR
The present review will focus on the current understanding of the impact of ageing on NOX biology and its consequences for age-related lung disease, particularly COPD, and the implications of altered NoX biology for current and future antioxidant-based strategies aimed at treating these diseases.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 455 REFERENCES
mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases
TLDR
This review assesses the use of mTOR inhibitors to treat age-related pathologies, discusses possible molecular mechanisms of action where evidence is available, and considers strategies to minimize undesirable side effects.
Finding Ponce de Leon’s Pill: Challenges in Screening for Anti-Aging Molecules
TLDR
The strategies employed, and the progress made, in identifying compounds capable of extending lifespan in organisms ranging from invertebrates to mice are summarized and the formidable challenges in translating this work to human therapies are discussed.
Interventions to Slow Aging in Humans: Are We Ready?
TLDR
There was consensus that there is sufficient evidence that aging interventions will delay and prevent disease onset for many chronic conditions of adult and old age and their potential to be safe and effective in extending human healthspan.
Hsp90 inhibitors as senolytic drugs to extend healthy aging
TLDR
The significance of developing senotherapeutic approaches to specifically kill senescent cells (senolytics) or suppress the senescence-associated secretory phenotype (SASP) that drives sterile inflammation associated with aging to extend healthspan and potentially lifespan is highlighted.
Targeting glucose metabolism for healthy aging
TLDR
It is highlighted that calorie restriction improves glucoregulatory control and extends both lifespan and healthspan in model organisms, but it is indicated more practical interventions (i.e., calorie restriction mimetics) are desirable for clinical application in humans.
...
1
2
3
4
5
...